ImmunoPrecise Antibodies Ltd. Files 6-K, Incorporates Exhibit
Ticker: HYFT · Form: 6-K · Filed: Jul 17, 2024 · CIK: 1715925
| Field | Detail |
|---|---|
| Company | Immunoprecise Antibodies LTD. (HYFT) |
| Form Type | 6-K |
| Filed Date | Jul 17, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration-statement, disclosure
TL;DR
IPA files 6-K, incorporating an exhibit into its F-3. Nothing new, just housekeeping.
AI Summary
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on July 17, 2024, to incorporate by reference Exhibit 99.1 into its F-3 Registration Statement (File No. 333-273197). The company is incorporated in British Columbia and its principal executive offices are located in Victoria, British Columbia.
Why It Matters
This filing indicates an update or addition to the company's registration statement, which could be relevant for investors tracking its ongoing capital-raising or disclosure activities.
Risk Assessment
Risk Level: low — This is a routine administrative filing (6-K) that incorporates previously filed information, not announcing new material events.
Key Players & Entities
- ImmunoPrecise Antibodies Ltd. (company) — Registrant
- 333-273197 (registration_statement_file_number) — Form F-3 File Number
- 001-39530 (commission_file_number) — SEC File Number
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to incorporate by reference Exhibit 99.1 into ImmunoPrecise Antibodies Ltd.'s Registration Statement on Form F-3 (File No. 333-273197).
When was this Form 6-K filed?
This Form 6-K was filed on July 17, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at 3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8.
Does ImmunoPrecise Antibodies Ltd. file annual reports under Form 20-F or Form 40-F?
The company indicates it files annual reports under Form 20-F, not Form 40-F.
What is the Commission File Number for ImmunoPrecise Antibodies Ltd.?
The Commission File Number for ImmunoPrecise Antibodies Ltd. is 001-39530.
Filing Stats: 183 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2024-07-16 21:41:01
Filing Documents
- form6k.htm (6-K) — 4KB
- exhibit99-1.htm (EX-99.1) — 9KB
- 0001062993-24-013856.txt ( ) — 15KB
From the Filing
ImmunoPrecise Antibodies Ltd.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2024 . Commission File Number: 001-39530 ImmunoPrecise Antibodies Ltd. (Exact Name of Registrant as Specified in Charter) 3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F INCORPORATION BY REFERENCE Exhibit 99.1 of this Form 6-K is incorporated by reference into the Registrant's Registration Statement on Form F-3 ( File No. 333-273197 ). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMUNOPRECISE ANTIBODIES LTD. Date: July 16, 2024 By: /s/ Kristin Taylor Name: Kristin Taylor Title: Chief Financial Officer EXHIBIT INDEX 99.1 Press Release dated July 16, 2024